Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2020-09-17 Investor Presentation
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Investor Presentation September 2020 18 pages 3.4MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor presentation | September 2020' and contains detailed information about the company's capital structure, board of directors, business strategy, product lines, market opportunities, and future plans. It includes numerous charts, images, and descriptions aimed at informing investors about the company's operations and market positioning. There are no financial statements or regulatory filings, nor is it a transcript or announcement of voting results. The content is consistent with a detailed presentation designed for investors to understand the company's strategy and prospects. Therefore, the document fits the category of an Investor Presentation (IP). The document length (9987 characters) supports it being a full presentation rather than a brief announcement or summary.
2020-09-17 English
Interim decision reached on scheduling of CBD 2 pages 175.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 9 September 2020 from ECS Botanics Ltd. It discusses an interim regulatory decision regarding the scheduling of CBD by Australian regulatory committees (ACMS and ACCS under TGA). The announcement provides updates on the company's medicinal cannabis project and hemp food business strategy. There are no financial statements, detailed financial data, or comprehensive report content. The document is a market update on regulatory and business developments rather than a formal financial report or detailed investor presentation. It is not a full annual or interim report, earnings release, or audit report. The document is a regulatory announcement informing the market about regulatory changes and company progress, fitting best under Regulatory Filings (RNS) as a general regulatory announcement and market update.
2020-09-08 English
Appendix 4G and Corporate Governance Statement 31 pages 441.2KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a detailed disclosure related to corporate governance practices and compliance with ASX Corporate Governance Council recommendations for the financial year ended 30 June 2020. The document includes a key to where governance disclosures can be found, and it explicitly states it is not a substitute for the corporate governance statement but a verification tool. It does not contain financial statements or management discussion of financial results but focuses on governance disclosures and compliance. This matches the description of a Governance Information filing, which details the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is the governance report itself, not just an announcement or certification. Therefore, the appropriate classification is Governance Information (CGR).
2020-08-27 English
Appendix 4E and Annual Report 53 pages 796.1KB
Annual Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4E' and is for ECS Botanics Holdings Limited for the year ended 30 June 2020. It contains detailed financial information including revenue, net loss, dividends, net tangible assets per security, earnings per share, and a comprehensive table of contents listing sections such as Directors' Report, Auditor's Independence Declaration, Consolidated Financial Statements, Notes to Financial Statements, Directors' Declaration, Independent Auditor's Report, and Corporate Governance Statement. The document also includes detailed information about the board of directors, company secretary, principal activities, and a review of operations. The length is substantial (15,000 characters), and the content includes full financial statements and management discussion, indicating this is the full annual report rather than a brief announcement or a certification. The presence of an Independent Auditor's Report and detailed financial statements confirms this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2020-08-26 English
Secondary Trading Notice & Appendix 2A 15 pages 290.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 26 August 2020, titled 'Secondary Trading Notice' and includes an Appendix 2A form for application for quotation of securities. It discusses the issuance of shares under a share purchase plan and compliance with the Corporations Act 2001. The content is regulatory in nature, related to securities issuance and trading notices, and includes detailed compliance statements and application for quotation of securities. It does not contain financial statements, earnings data, management discussion, or other report content. It is not a report itself but a regulatory announcement related to capital raising and securities issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-08-25 English
ECS Botanics SPP Closes Heavily Oversubscribed 1 pa
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 August 2020 regarding the closure of a Share Purchase Plan (SPP) that was heavily oversubscribed. It details the amount raised, the number of shares to be issued, and the issue price. There is no financial report, earnings data, or management discussion. The content focuses on capital raising activity and share issuance. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication, so it is not RPA. No officer certification or regulatory compliance content is present, so not RNS. Hence, the classification is CAP with high confidence.
2020-08-17 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.